Literature DB >> 7514470

Clinical experience with transurethral microwave thermotherapy for chronic nonbacterial prostatitis and prostatodynia.

N G Choi1, S H Soh, T H Yoon, M H Song.   

Abstract

Chronic prostatitis and prostatodynia are troublesome disorders that are not responsive to any kind of treatment. Patients with treatment-resistant chronic nonbacterial prostatitis (n = 61) or prostatodynia (n = 17) for longer than 3 years underwent a single 1-hour session of transurethral microwave thermotherapy (TUMT) using the Prostatron. Complete symptom disappearance was obtained in 23% of patients and a partial response in 43%. Of the patients with prostatitis, 46% showed normalization and 31% an improvement of the leukocyte count in expressed prostatic secretion. In patients with prostatodynia, the corresponding figures were 35% and 41%. Most complications were temporary, but there was one case of epididymitis and one of reduction in the volume of the ejaculate. TUMT is well tolerated and safe, and it is effective in relieving the symptoms of many patients with nonbacterial prostatitis or prostatodynia. The possible adverse effects on fertility and urinary continence require further study.

Entities:  

Mesh:

Year:  1994        PMID: 7514470     DOI: 10.1089/end.1994.8.61

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  5 in total

1.  Update on minimally invasive therapy for chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Christof Kastner
Journal:  Curr Urol Rep       Date:  2008-07       Impact factor: 3.092

Review 2.  Chronic prostatitis/chronic pelvic pain syndrome in elderly men: toward better understanding and treatment.

Authors:  Michel A Pontari
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 3.  Minimally invasive therapies for prostatitis.

Authors:  Peter Zvara; Jeffrey B Folsom; Mark K Plante
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 3.092

4.  Model-based feasibility assessment and evaluation of prostate hyperthermia with a commercial MR-guided endorectal HIFU ablation array.

Authors:  Vasant A Salgaonkar; Punit Prakash; Viola Rieke; Eugene Ozhinsky; Juan Plata; John Kurhanewicz; I-C Joe Hsu; Chris J Diederich
Journal:  Med Phys       Date:  2014-03       Impact factor: 4.071

Review 5.  Advanced therapy for prostatitis: minimally invasive and invasive therapies.

Authors:  Assaad El-Hakim; Darshan K Shah; Arthur D Smith
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.